Dasatinib
10 NDCs across 9 manufacturers|8 Generic,2 Brand
Dasatinib is used to treat lymphoid leukemia and myeloid leukemia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jun 28, 2006, and the first generic was approved Jun 10, 2016. FDA's Orange Book lists 54 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $569 million on Dasatinib across 44,000 claims for 7,778 beneficiaries.
Dasatinib is available as 10 NDCs from 9 manufacturers (8 generic, 2 brand), with NADAC prices from $26.18 to $591.18 per EA — the most expensive product costs about 23× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
10
8G / 2B
Manufacturers
9
competing in market
Price Spread
$26.18 – $591.18
per EA
7d Activity
avg -0.9% WoW · of 10 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
9 manufacturers producing DASATINIB(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SPRYCEL 100 MG TABLET | $591.1812 per EA | — |
SPRYCEL 50 MG TABLET | $327.4239 per EA | — |
DASATINIB 100 MG TABLET | $26.1835 per EA | -0.87% |
DASATINIB 100 MG TABLET | $26.1835 per EA | -0.87% |
DASATINIB 100 MG TABLET | $26.1835 per EA | -0.87% |
DASATINIB 100 MG TABLET | $26.1835 per EA | -0.87% |
DASATINIB 100 MG TABLET | $26.1835 per EA | -0.87% |
DASATINIB 100 MG TABLET | $26.1835 per EA | -0.87% |
DASATINIB 100 MG TABLET | $26.1835 per EA | -0.87% |
DASATINIB 100 MG TABLET | $26.1835 per EA | -0.87% |
Frequently Asked Questions
What is Dasatinib used to treat?
Dasatinib is used to treat lymphoid leukemia and myeloid leukemia, per the National Library of Medicine's MED-RT classification.
When did Dasatinib become available as a generic?
FDA approved the first generic Dasatinib (ANDA) on Jun 10, 2016. The Orange Book currently lists 54 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Dasatinib?
In 2024, Medicare Part D spent $569 million on Dasatinib across 44,000 claims for 7,778 beneficiaries.
How many Dasatinib products are on the market?
The Dasatinib drug market contains 10 NDCs from 9 manufacturers — 8 generic and 2 brand products.
What is the price range for Dasatinib?
NADAC reference prices for Dasatinib range from $26.1835 to $591.1812 per EA — the most expensive product costs about 23× the cheapest.
Is generic Dasatinib cheaper than brand?
The average generic NADAC for Dasatinib is $26.1835 per EA, versus $459.3025 for brand-labeled products — brand versions average about 18× the generic price.
Which manufacturers make Dasatinib?
9 manufacturers list Dasatinib in NADAC. Ranked by number of NDCs, the largest are E.R. Squibb & Sons, L.L.C. (2), Aurobindo Pharma Limited (1), Apotex Corp. (1), Prasco Laboratories (1), Teva Pharmaceuticals USA Inc. (1).
How has the price of Dasatinib changed recently?
Over the past 7 days, 0 Dasatinib NDCs rose and 8 fell, with a market-wide average change of -0.9%.